Earlier this month, Novavax participated in investor-focused healthcare conferences hosted by Citigroup and Cantor Fitzgerald ...
Updated COVID vaccines are necessary, just as flu vaccines are updated because immunity wanes with time, even among those vaccinated and those that have had prior COVID infections. In addition, the ...
Novavax receives a Hold rating, reflecting neutral fundamentals despite a Q1 earnings beat and strong recent price momentum. NVAX's upside hinges on executing strategic partnerships, notably with ...
Novavax reported that partners Sanofi and Takeda have secured approvals for an updated Nuvaxovid formulation targeting the SARS-CoV-2 XFG variant for the 2026–2027 vaccination season across the U.S., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results